16th Nov 2007 18:29
GlaxoSmithKline PLC16 November 2007 This announcement replaces the original announcement released on 16/11/07 at 17:29, RNS No: 9431H. The number of shares that the Company holds in treasury should have read491,744,158 and not 497,744,158 as previously stated. In addition the percentageof shares in treasury should have read 8.89% and not 9.00% as previously stated. All other details remain unchanged. The amended text appears below GlaxoSmithKline plc (the "Company") announces that in accordance with theauthority granted by shareholders at the Company's Annual General Meeting on 23May 2007 it purchased 2,500,000 of its Ordinary shares of 25 pence each("shares") on 16 November 2007 at a price of 1195.5p pence per share. The Company intends to hold these shares in Treasury. Following the purchase of these shares, the Company holds 491,744,158 of itsshares in Treasury, representing 8.89% of the total voting rights in theCompany. The Company has 5,527,531,067 shares in issue (excluding Treasury shares). Thisnumber represents the total voting rights in the Company and may be used byshareholders as the denominator for the calculations by which they can determineif they are required to notify their interest in, or a change to their interestin the Company under the Financial Services Authority's Disclosure andTransparency Rules. This announcement does not constitute, or form part of, an offer or anysolicitation of an offer to purchase or subscribe for securities in anyjurisdiction and is in conformity with the Financial Services Authority'sDisclosure and Transparency Rules. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline